Advertisement
Screener

Beyond Air, Inc. (XAIR) Cash and Cash Equivalents, Period Increase (Decrease)

Beyond Air, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

Beyond Air, Inc. (XAIR) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.19 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-30.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-30

  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$551.00K.
  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$3.44M, a 19194.44% decline year-over-year.
  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$1.95M.
  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $7.13M.
  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.19M.
  • Beyond Air, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$122.00K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 8 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2017-12-31-$551.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
-$3.99M
derived: sum of 2 quarters · filed 2018-03-30
-$5.94M
derived: sum of 3 quarters · filed 2018-03-30
$1.19M
10-K · filed 2018-03-30
2017-09-30-$3.44M
10-Q · filed 2017-11-03
-$5.39M
derived: sum of 2 quarters · filed 2017-11-03
$1.75M
10-Q · filed 2017-11-03
$1.73M
derived: sum of 4 quarters · filed 2018-03-30
2017-06-30-$1.95M
10-Q · filed 2017-08-11
$5.18M
10-Q · filed 2017-08-11
$5.17M
derived: sum of 3 quarters · filed 2018-03-30
$5.19M
derived: sum of 4 quarters · filed 2018-03-30
2017-03-31$7.13M
10-Q · filed 2017-05-15
$7.12M
derived: sum of 2 quarters · filed 2018-03-30
$7.14M
derived: sum of 3 quarters · filed 2018-03-30
$7.11M
derived: sum of 4 quarters · filed 2018-03-30
2016-12-31-$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
$5.00K
derived: sum of 2 quarters · filed 2018-03-30
-$23.00K
derived: sum of 3 quarters · filed 2018-03-30
-$122.00K
10-K · filed 2018-03-30
-$5.49K
10-K · filed 2017-03-31
2016-09-30$18.00K
10-Q · filed 2017-11-03
-$10.00K
derived: sum of 2 quarters · filed 2017-11-03
-$109.00K
10-Q · filed 2017-11-03
2016-06-30-$28.00K
10-Q · filed 2017-08-11
-$127.00K
10-Q · filed 2017-08-11
2016-03-31-$99.00K
10-Q · filed 2017-05-15
2015-12-31$5.53K
10-K · filed 2017-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B